Cargando…
Fulminant demyelinating encephalomyelitis: Insights from antibody studies and neuropathology
OBJECTIVES: Antibodies to myelin oligodendrocyte glycoprotein (MOG) are detectable in inflammatory demyelinating CNS diseases, and MOG antibody–associated diseases seem to have a better prognosis despite occasionally severe presentations. METHODS: We report the case of a 71-year-old patient with acu...
Autores principales: | Di Pauli, Franziska, Höftberger, Romana, Reindl, Markus, Beer, Ronny, Rhomberg, Paul, Schanda, Kathrin, Sato, Douglas, Fujihara, Kazuo, Lassmann, Hans, Schmutzhard, Erich, Berger, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4635550/ https://www.ncbi.nlm.nih.gov/pubmed/26587556 http://dx.doi.org/10.1212/NXI.0000000000000175 |
Ejemplares similares
-
NMDA receptor antibodies: A rare association in inflammatory demyelinating diseases
por: Ramberger, Melanie, et al.
Publicado: (2015) -
Inflammatory demyelinating diseases of the central nervous system
por: Höftberger, Romana, et al.
Publicado: (2018) -
Human antibodies against the myelin oligodendrocyte glycoprotein can cause complement-dependent demyelination
por: Peschl, Patrick, et al.
Publicado: (2017) -
Diagnostic challenges and pitfalls of myelin oligodendrocyte glycoprotein antibody–associated demyelination: Lessons from neuropathology
por: Höftberger, Romana, et al.
Publicado: (2019) -
Myelin Oligodendrocyte Glycoprotein: Deciphering a Target in Inflammatory Demyelinating Diseases
por: Peschl, Patrick, et al.
Publicado: (2017)